Calamos Advisors
ALXN

Calamos Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-169,936
Closed -$31.2M 1054
2021
Q2
$31.2M Buy
169,936
+28,983
+21% +$5.32M 0.14% 171
2021
Q1
$21.6M Buy
140,953
+23,325
+20% +$3.57M 0.12% 186
2020
Q4
$18.4M Buy
117,628
+8,468
+8% +$1.32M 0.11% 212
2020
Q3
$12.5M Sell
109,160
-9,580
-8% -$1.1M 0.08% 242
2020
Q2
$13.3M Sell
118,740
-289,115
-71% -$32.4M 0.09% 224
2020
Q1
$36.6M Sell
407,855
-276,100
-40% -$24.8M 0.29% 98
2019
Q4
$74M Buy
683,955
+102,242
+18% +$11.1M 0.37% 64
2019
Q3
$57M Sell
581,713
-67,510
-10% -$6.61M 0.31% 83
2019
Q2
$85M Sell
649,223
-38,409
-6% -$5.03M 0.47% 42
2019
Q1
$93M Sell
687,632
-46,730
-6% -$6.32M 0.58% 31
2018
Q4
$71.5M Buy
734,362
+18,083
+3% +$1.76M 0.47% 46
2018
Q3
$99.6M Buy
716,279
+93,533
+15% +$13M 0.55% 29
2018
Q2
$77.3M Buy
622,746
+27,168
+5% +$3.37M 0.47% 34
2018
Q1
$66.4M Buy
595,578
+113,946
+24% +$12.7M 0.43% 46
2017
Q4
$57.6M Buy
481,632
+190,921
+66% +$22.8M 0.29% 54
2017
Q3
$40.8M Sell
290,711
-43,777
-13% -$6.14M 0.32% 89
2017
Q2
$40.7M Buy
334,488
+268,287
+405% +$32.6M 0.3% 80
2017
Q1
$8.03M Buy
66,201
+45,119
+214% +$5.47M 0.06% 303
2016
Q4
$2.58M Sell
21,082
-256,494
-92% -$31.4M 0.02% 449
2016
Q3
$34M Sell
277,576
-217,463
-44% -$26.6M 0.24% 134
2016
Q2
$57.8M Sell
495,039
-34,347
-6% -$4.01M 0.41% 69
2016
Q1
$73.7M Buy
529,386
+6,202
+1% +$863K 0.49% 52
2015
Q4
$99.8M Buy
523,184
+193,450
+59% +$36.9M 0.63% 33
2015
Q3
$51.6M Buy
329,734
+226,350
+219% +$35.4M 0.36% 85
2015
Q2
$18.7M Buy
103,384
+82,261
+389% +$14.9M 0.12% 202
2015
Q1
$3.66M Sell
21,123
-19,086
-47% -$3.31M 0.02% 412
2014
Q4
$7.44M Buy
40,209
+209
+0.5% +$38.7K 0.05% 303
2014
Q3
$6.63M Sell
40,000
-1,620
-4% -$269K 0.04% 297
2014
Q2
$6.5M Buy
41,620
+21,620
+108% +$3.38M 0.04% 300
2014
Q1
$3.04M Sell
20,000
-9,000
-31% -$1.37M 0.02% 374
2013
Q4
$3.86M Buy
29,000
+12,000
+71% +$1.6M 0.02% 341
2013
Q3
$1.98M Hold
17,000
0.01% 402
2013
Q2
$1.57M Buy
+17,000
New +$1.57M 0.01% 406